ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,066Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 52

$322K Total Retail Price of All Prescriptions

Rank: 10 out of 52

204 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 204 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 204 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 283 214 S3 1 3
LEVOTHYROXINE SODIUM 252 208 2 5
FUROSEMIDE 241 220 3 7
METOPROLOL TARTRATE 219 202 4 11
WARFARIN SODIUM 214 212 5 13
TRAZODONE HCL 210 207 6 29
POLYETHYLENE GLYCOL 3350 199 164 7 41
LISINOPRIL 188 162 8 2
QUETIAPINE FUMARATE 170 143 9 49
FENTANYL 165 163 S2 10 57
OMEPRAZOLE 162 161 11 6
ESCITALOPRAM OXALATE 162 125 11 59
SIMVASTATIN 155 122 13 1
GABAPENTIN 137 122 14 10
AMLODIPINE BESYLATE 130 128 15 4
RANITIDINE HCL 119 106 16 23
POTASSIUM CHLORIDE 112 112 17 18
TRAMADOL HCL 111 102 18 14
ALBUTEROL SULFATE 104 99 19 97
SERTRALINE HCL 90 78 20 24
VENLAFAXINE HCL 87 66 21 135
ATENOLOL 87 81 21 17
OXYCODONE HCL 83 65 S2 23 21
SEROQUEL 79 70 24 102
NOVOLIN N 79 78 24 140
HYDROCHLOROTHIAZIDE 79 79 24 9
DIVALPROEX SODIUM 75 52 27 108
DONEPEZIL HCL 68 68 28 26
METFORMIN HCL 64 52 29 8
BUSPIRONE HCL 60 60 30 95
CEPHALEXIN 58 55 31 77
FLUOXETINE HCL 57 49 32 64
GLIPIZIDE 56 42 33 37
PREDNISONE 56 27 33 64
IPRATROPIUM BROMIDE 52 52 35 166
ALENDRONATE SODIUM 51 51 36 42
NAMENDA 51 49 36 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.